Standout Papers
- Ovarian cancer (2014)
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial (2015)
- Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial (2003)
- Antiangiogenic therapy in oncology: current status and future directions (2016)
- Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI (2006)
Immediate Impact
10 by Nobel laureates 9 from Science/Nature 83 standout
Citing Papers
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Works of Gordon C. Jayson being referenced
Ovarian cancer
2014 Standout
Distribution and Clinical Significance of Heparan Sulfate Proteoglycans in Ovarian Cancer
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gordon C. Jayson | 4664 | 4036 | 4023 | 251 | 13.7k | |
| Gordon Rustin | 3993 | 5054 | 5247 | 244 | 15.7k | |
| Gabriella Ferrandina | 4607 | 5549 | 4763 | 489 | 15.4k | |
| Christian Marth | 5690 | 3023 | 5182 | 397 | 13.6k | |
| Stan B. Kaye | 8573 | 3535 | 9366 | 214 | 18.9k | |
| Andrew Berchuck | 8006 | 6748 | 5699 | 353 | 19.5k | |
| Beth Y. Karlan | 7818 | 6389 | 6294 | 328 | 18.4k | |
| Gunnar B. Kristensen | 3491 | 7386 | 4200 | 257 | 14.3k | |
| Hiroaki Kajiyama | 3123 | 1982 | 2390 | 413 | 9.8k | |
| Ross S. Berkowitz | 4518 | 5343 | 2702 | 437 | 18.3k | |
| Rainer Kimmig | 2202 | 3489 | 3537 | 395 | 10.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...